|
WO2000053758A2
(en)
*
|
1999-03-08 |
2000-09-14 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
|
WO2000053756A2
(en)
*
|
1999-03-08 |
2000-09-14 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
GB9701684D0
(en)
|
1997-01-28 |
1997-03-19 |
Smithkline Beecham Plc |
Novel compounds
|
|
WO1999066041A1
(en)
|
1998-06-16 |
1999-12-23 |
Human Genome Sciences, Inc. |
94 human secreted proteins
|
|
US20020137890A1
(en)
|
1997-03-31 |
2002-09-26 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
WO2000053751A1
(en)
*
|
1999-03-08 |
2000-09-14 |
Genentech, Inc. |
Methods and compositions for inhibiting neoplastic cell growth
|
|
WO1999060127A2
(en)
|
1998-05-15 |
1999-11-25 |
Genentech, Inc. |
Il-17 homologous polypeptides and therapeutic uses thereof
|
|
WO2000053754A1
(en)
*
|
1999-03-08 |
2000-09-14 |
Genentech, Inc. |
Compositions and methods for the treatment of tumor
|
|
US6579520B2
(en)
*
|
1998-05-15 |
2003-06-17 |
Genentech, Inc. |
IL-17 related mammalian cytokine polypeptides (IL-17E)
|
|
WO2000053752A2
(en)
*
|
1999-03-08 |
2000-09-14 |
Genentech, Inc. |
Promotion or inhibition of angiogenesis and cardiovascularization
|
|
WO2000070050A1
(en)
*
|
1999-05-14 |
2000-11-23 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
|
US7057017B2
(en)
|
1997-04-16 |
2006-06-06 |
Millennium Pharmaceuticals, Inc. |
Human dickkopf-related protein and nucleic acid molecules and uses therefor
|
|
US6949358B1
(en)
|
1997-06-11 |
2005-09-27 |
Human Genome Sciences, Inc. |
Human tumor necrosis factor receptor TR9
|
|
US6358508B1
(en)
|
1997-06-11 |
2002-03-19 |
Human Genome Sciences, Inc. |
Antibodies to human tumor necrosis factor receptor TR9
|
|
WO1999007893A1
(en)
*
|
1997-08-08 |
1999-02-18 |
University Of Washington |
ISOLATION OF A NOVEL SENESCENCE-FACTOR GENE, p23
|
|
US20030027262A1
(en)
|
1997-09-18 |
2003-02-06 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US7105640B2
(en)
|
1997-10-17 |
2006-09-12 |
Genentech, Inc. |
Anti-pro792 antibodies
|
|
US20030069178A1
(en)
|
1997-10-17 |
2003-04-10 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US6391311B1
(en)
|
1998-03-17 |
2002-05-21 |
Genentech, Inc. |
Polypeptides having homology to vascular endothelial cell growth factor and bone morphogenetic protein 1
|
|
US20030199436A1
(en)
|
1997-10-17 |
2003-10-23 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US6808890B2
(en)
|
1999-07-28 |
2004-10-26 |
Nuvelo, Inc. |
Method of detecting a cancerous cell expressing EGFL6, and EGF mutif protein
|
|
US6392019B1
(en)
|
1997-11-22 |
2002-05-21 |
John Ford |
Antibodies specific for EGF motif proteins
|
|
US8007798B2
(en)
|
1997-11-21 |
2011-08-30 |
Genentech, Inc. |
Treatment of complement-associated disorders
|
|
EP1481990B1
(en)
*
|
1997-11-21 |
2007-06-06 |
Genentech, Inc. |
A-33 related antigens and their pharmacological uses
|
|
US8088386B2
(en)
|
1998-03-20 |
2012-01-03 |
Genentech, Inc. |
Treatment of complement-associated disorders
|
|
US7192589B2
(en)
|
1998-09-16 |
2007-03-20 |
Genentech, Inc. |
Treatment of inflammatory disorders with STIgMA immunoadhesins
|
|
CA2309897A1
(en)
|
1997-11-22 |
1999-06-03 |
Hyseq, Inc. |
A novel egf motif protein obtained from a cdna library of fetal liver-spleen
|
|
US7446181B2
(en)
|
1998-01-15 |
2008-11-04 |
Millennium Pharmaceuticals, Inc. |
Antibodies that bind human Dickkopf-1 proteins
|
|
US7033772B1
(en)
|
1998-01-15 |
2006-04-25 |
Millennium Pharmaceuticals, Inc. |
Methods of identifying inhibitors of fatty acid transport proteins (FATP)
|
|
US6203979B1
(en)
|
1998-01-16 |
2001-03-20 |
Incyte Pharmaceuticals, Inc. |
Human protease molecules
|
|
US7045333B1
(en)
|
1998-01-16 |
2006-05-16 |
Incyte Corporation |
Human protease molecules
|
|
US6566498B1
(en)
|
1998-02-06 |
2003-05-20 |
Human Genome Sciences, Inc. |
Human serine protease and serpin polypeptides
|
|
AU758353B2
(en)
|
1998-03-17 |
2003-03-20 |
Genentech Inc. |
Polypeptides homologous to VEGF and BMP1
|
|
US7067636B2
(en)
|
1998-05-06 |
2006-06-27 |
Genentech, Inc. |
Anti-pro 1017 antibodies
|
|
US7081521B2
(en)
|
1998-05-06 |
2006-07-25 |
Genentech, Inc. |
Anti-PRO788 antibodies
|
|
US7488795B2
(en)
|
1998-05-07 |
2009-02-10 |
Genentech, Inc. |
PRO846 polypeptides
|
|
US20030186368A1
(en)
|
1998-05-13 |
2003-10-02 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
EP3112468A1
(en)
*
|
1998-05-15 |
2017-01-04 |
Genentech, Inc. |
Il-17 homologous polypeptides and therapeutic uses thereof
|
|
US7771719B1
(en)
|
2000-01-11 |
2010-08-10 |
Genentech, Inc. |
Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
|
|
EP1865061A3
(en)
*
|
1998-05-15 |
2007-12-19 |
Genentech, Inc. |
IL-17 homologous polypeptides and therapeutic uses thereof
|
|
US7019115B2
(en)
|
1998-05-22 |
2006-03-28 |
Genentech, Inc. |
Pro1017 polypeptides
|
|
US6171843B1
(en)
|
1998-06-01 |
2001-01-09 |
Incyte Pharmaceuticals, Inc. |
Human peptidyl-prolyl isomerases
|
|
EP1095159A4
(en)
*
|
1998-07-15 |
2003-01-02 |
Human Genome Sciences Inc |
Bone Morphogenetic Protein
|
|
US7220835B2
(en)
|
1998-07-30 |
2007-05-22 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
EP1111060A4
(en)
*
|
1998-08-31 |
2003-01-02 |
Long Yu |
HUMAN LYSOZYME GENE, CODED POLYPEPTIDE AND METHOD FOR THE PRODUCTION THEREOF
|
|
US6844148B1
(en)
|
1998-09-24 |
2005-01-18 |
Pharmacia & Upjohn Company |
Alzheimer's disease secretase, APP substrates therefor, and uses therefor
|
|
US6699671B1
(en)
|
1998-09-24 |
2004-03-02 |
Pharmacia & Upjohn Company |
Alzheimer's disease secretase, APP substrates therefor, and uses therefor
|
|
SG113454A1
(en)
|
1998-09-24 |
2005-08-29 |
Upjohn Co |
Alzheimer's disease secretase
|
|
WO2000020590A2
(en)
*
|
1998-10-06 |
2000-04-13 |
Incyte Pharmaceuticals, Inc. |
G-protein coupled receptor proteins
|
|
US20030203446A1
(en)
|
1998-10-07 |
2003-10-30 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US6960433B1
(en)
|
1998-10-19 |
2005-11-01 |
Diadexus, Inc. |
Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
|
|
WO2000024774A2
(en)
*
|
1998-10-28 |
2000-05-04 |
Incyte Pharmaceuticals, Inc. |
Growth factor related molecules
|
|
US6432673B1
(en)
|
1998-12-07 |
2002-08-13 |
Zymogenetics, Inc. |
Growth factor homolog ZVEGF3
|
|
AU2162000A
(en)
*
|
1998-12-10 |
2000-06-26 |
Zymogenetics Inc. |
Seven transmembrane domain receptor zsig56
|
|
EP2075335A3
(en)
*
|
1998-12-22 |
2009-09-30 |
Genentech, Inc. |
Methods and compositions for inhibiting neoplastic cell growth
|
|
WO2000039284A1
(en)
*
|
1998-12-30 |
2000-07-06 |
Millennium Pharmaceuticals, Inc. |
Secreted proteins and nucleic acids encoding them
|
|
US7456007B1
(en)
|
1998-12-31 |
2008-11-25 |
Elan Pharmaceuticals, Inc. |
β-secretase enzyme compositions and methods
|
|
US7115410B1
(en)
|
1999-02-10 |
2006-10-03 |
Elan Pharmaceuticals, Inc. |
β-secretase enzyme compositions and methods
|
|
CA2359785A1
(en)
|
1999-02-10 |
2000-08-17 |
John P. Anderson |
.beta.-secretase enzyme compositions and methods
|
|
AU3737500A
(en)
*
|
1999-03-12 |
2000-09-28 |
Genentech Inc. |
Method of preventing the death of retinal neurons and treating ocular diseases
|
|
AU4008500A
(en)
*
|
1999-04-06 |
2000-10-23 |
Eli Lilly And Company |
Platelet-derived growth factor related gene and protein
|
|
WO2000061754A2
(en)
*
|
1999-04-09 |
2000-10-19 |
Curagen Corporation |
Human proteins and polynucleotides encoding them
|
|
US7214656B2
(en)
|
1999-04-28 |
2007-05-08 |
Genentech, Inc. |
PRO792 polypeptides
|
|
AU4700300A
(en)
*
|
1999-05-07 |
2000-11-21 |
Human Genome Sciences, Inc. |
Serine proteases
|
|
AU4640600A
(en)
*
|
1999-05-11 |
2000-11-21 |
Eli Lilly And Company |
Amyloid precursor protein protease and related nucleic acid compounds
|
|
CN1244584A
(zh)
*
|
1999-05-14 |
2000-02-16 |
北京医科大学 |
具有免疫细胞趋化和造血刺激活性的趋化因子
|
|
WO2001004301A1
(fr)
*
|
1999-07-08 |
2001-01-18 |
Helix Research Institute |
Proteine transporteuse d'acides gras et gene codant cette proteine
|
|
US7001766B2
(en)
|
1999-07-20 |
2006-02-21 |
Curagen Corporation |
Nucleic acid sequences encoding human angiopoietin-like polypeptides
|
|
KR100543857B1
(ko)
*
|
1999-09-01 |
2006-01-23 |
제넨테크, 인크. |
혈관신생 및 심혈관형성의 촉진 또는 억제
|
|
US6429303B1
(en)
|
1999-09-03 |
2002-08-06 |
Curagen Corporation |
Nucleic acids encoding members of the human B lymphocyte activation antigen B7 family and methods of using the same
|
|
JP2003512819A
(ja)
*
|
1999-09-03 |
2003-04-08 |
ヒューマン ジノーム サイエンシーズ， インコーポレイテッド |
Ｂ７様ポリヌクレオチド、ポリペプチドおよび抗体
|
|
WO2001019856A2
(en)
*
|
1999-09-13 |
2001-03-22 |
Curagen Corporation |
Secreted human proteins, polynucleotides encoding them and methods of using the same
|
|
AU7599400A
(en)
*
|
1999-09-23 |
2001-04-24 |
Millennium Pharmaceuticals, Inc. |
Fatty acid transport proteins
|
|
US6780627B1
(en)
|
2000-01-31 |
2004-08-24 |
Millennium Pharmaceuticals, Inc. |
22438, 23553, 25278, and 26212 novel human sulfatases
|
|
WO2001023569A1
(en)
*
|
1999-09-29 |
2001-04-05 |
Hyseq, Inc. |
Cytokine receptor materials and methods
|
|
US6893637B1
(en)
|
1999-10-21 |
2005-05-17 |
Zymogenetics, Inc. |
Method of treating fibrosis
|
|
CA2388914A1
(en)
*
|
1999-11-12 |
2001-05-17 |
Human Genome Sciences, Inc. |
15 human secreted proteins
|
|
AU784746B2
(en)
|
1999-11-18 |
2006-06-08 |
Dendreon Corporation |
Nucleic acids encoding endotheliases, endotheliases and uses thereof
|
|
US7514408B1
(en)
|
1999-12-02 |
2009-04-07 |
Elan Pharmaceuticals, Inc. |
β-secretase enzyme compositions and methods
|
|
US6682902B2
(en)
|
1999-12-16 |
2004-01-27 |
Schering Aktiengesellschaft |
DNA encoding a novel RG1 polypeptide
|
|
US7122632B2
(en)
|
1999-12-23 |
2006-10-17 |
Zymogenetics, Inc. |
Soluble Interleukin-20 receptor
|
|
JP4741139B2
(ja)
*
|
1999-12-23 |
2011-08-03 |
ザイモジェネティクス， インコーポレイテッド |
可溶性インターロイキン−２０レセプター
|
|
ES2458349T3
(es)
*
|
1999-12-23 |
2014-05-05 |
Genentech, Inc. |
Polipéptidos homólogos IL-17 y usos terapéuticos de los mismos
|
|
US6610286B2
(en)
|
1999-12-23 |
2003-08-26 |
Zymogenetics, Inc. |
Method for treating inflammation using soluble receptors to interleukin-20
|
|
US20040043397A1
(en)
|
2000-01-11 |
2004-03-04 |
Genentech, Inc. |
IL-17 homologous polypeptides and therapeutic uses thereof
|
|
EP1242443A4
(en)
*
|
1999-12-23 |
2005-06-22 |
Nuvelo Inc |
NEW NUCLEIC ACIDS AND POLYPEPTIDES
|
|
JP2016047051A
(ja)
*
|
1999-12-23 |
2016-04-07 |
ジェネンテック， インコーポレイテッド |
Ｉｌ−１７相同的ポリペプチドとその治療上の用途
|
|
WO2001049707A1
(en)
*
|
2000-01-05 |
2001-07-12 |
The Board Of Trustees Of The Leland Stanford Junior University |
Gene involved in mineral deposition and uses thereof
|
|
AU784349C
(en)
*
|
2000-01-12 |
2006-09-28 |
Yale University |
Nogo receptor-mediated blockade of axonal growth
|
|
US7119165B2
(en)
|
2000-01-12 |
2006-10-10 |
Yale University |
Nogo receptor-mediated blockade of axonal growth
|
|
AU2001233702A1
(en)
*
|
2000-01-25 |
2001-08-07 |
Novartis Ag |
Disease-associated gene
|
|
AU2001233262A1
(en)
*
|
2000-02-03 |
2001-08-14 |
Dendreon Corporation |
Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
|
|
US6653448B1
(en)
*
|
2000-03-29 |
2003-11-25 |
Curagen Corporation |
Wnt-7B-like polypeptides and nucleic acids encoding same
|
|
WO2001096392A2
(en)
*
|
2000-06-15 |
2001-12-20 |
Millennium Pharmaceuticals, Inc. |
22109, a novel human thioredoxin family member and uses thereof
|
|
US20020156005A1
(en)
*
|
2000-09-25 |
2002-10-24 |
Meyers Rachel E. |
m32404, a novel human trypsin and uses thereof
|
|
US7718397B2
(en)
|
2000-03-21 |
2010-05-18 |
Genentech, Inc. |
Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
|
|
WO2001079466A2
(en)
*
|
2000-04-18 |
2001-10-25 |
Bayer Aktiengesellschaft |
Regulation of human epithin-like serine protease
|
|
EP1280923A2
(en)
|
2000-04-28 |
2003-02-05 |
Millennium Pharmaceuticals, Inc. |
14094, a human trypsin family member and uses thereof
|
|
US20030096969A1
(en)
|
2000-06-02 |
2003-05-22 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US20020168713A1
(en)
*
|
2000-06-06 |
2002-11-14 |
Curtis Rory A.J. |
46980, a novel human neuroligin family member and uses thereof
|
|
JP2004500863A
(ja)
|
2000-06-06 |
2004-01-15 |
ブリストル−マイヤーズ スクイブ カンパニー |
免疫調節に有用なｂ７関連核酸およびポリペプチド
|
|
US20030031675A1
(en)
|
2000-06-06 |
2003-02-13 |
Mikesell Glen E. |
B7-related nucleic acids and polypeptides useful for immunomodulation
|
|
EP2792747A1
(en)
*
|
2000-06-23 |
2014-10-22 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
|
|
EP1309620A2
(en)
*
|
2000-06-23 |
2003-05-14 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
|
|
CA2416538A1
(en)
*
|
2000-07-20 |
2002-01-31 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
|
|
JP2015037408A
(ja)
*
|
2000-07-20 |
2015-02-26 |
ジェネンテック， インコーポレイテッド |
血管形成に関連する障害を診断及び治療するための組成物と方法
|
|
CA2416713A1
(en)
*
|
2000-07-21 |
2002-01-31 |
Bristol-Myers Squibb Company |
Novel siglecs and uses thereof
|
|
JP5015404B2
(ja)
|
2000-08-08 |
2012-08-29 |
ザイモジェネティクス， インコーポレイテッド |
可溶性ｚｃｙｔｏｒ１１サイトカイン受容体
|
|
EP1445318A2
(en)
*
|
2000-08-24 |
2004-08-11 |
Genetech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
|
JP2004520810A
(ja)
*
|
2000-08-24 |
2004-07-15 |
ジェネンテック・インコーポレーテッド |
腫瘍の診断と治療のための組成物と方法
|
|
AU2001286205A1
(en)
*
|
2000-09-12 |
2002-03-26 |
Kirin Beer Kabushiki Kaisha |
Novel dendritic cell wall membrane and use thereof
|
|
EP1803733B1
(en)
|
2000-09-15 |
2010-03-10 |
ZymoGenetics, Inc. |
Polypeptides comprising the extracellular domains of IL-20RA and/or IL-20RB
|
|
EP1325020A4
(en)
*
|
2000-09-20 |
2004-12-15 |
Human Genome Sciences Inc |
21 HUMANE SECONDED PROTEINS
|
|
AU2001229563A1
(en)
*
|
2000-09-20 |
2002-04-02 |
Human Genome Sciences, Inc. |
21 human secreted proteins
|
|
NZ525422A
(en)
|
2000-10-06 |
2006-09-29 |
Biogen Idec Inc |
Isolated polynucleotides comprising a nucleic acid which encodes a polypeptide which modulates axonal growth in CNS neurons
|
|
EP1201681A1
(en)
|
2000-10-30 |
2002-05-02 |
Millennium Pharmaceuticals, Inc. |
"Fail" molecules and uses thereof
|
|
AU2002223784B2
(en)
|
2000-11-06 |
2007-01-18 |
Cancer ResearchTechnology Limited |
Imaging, diagnosis and treatment of disease
|
|
US20020111302A1
(en)
*
|
2000-11-30 |
2002-08-15 |
Y. Tom Tang |
Novel nucleic acids and polypeptides
|
|
JPWO2002057448A1
(ja)
*
|
2000-12-27 |
2004-05-20 |
第一ファインケミカル株式会社 |
新規ペプチド及びその活性
|
|
CA2443123A1
(en)
|
2001-04-10 |
2002-10-24 |
Agensys, Inc. |
Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
|
|
US20040038860A1
(en)
|
2002-05-17 |
2004-02-26 |
Allen Kristina M. |
Reagents and methods for modulating dkk-mediated interactions
|
|
US20030039999A1
(en)
*
|
2001-05-25 |
2003-02-27 |
Amgen, Inc. |
B7 related protein-2 molecules and uses thereof
|
|
US7125663B2
(en)
|
2001-06-13 |
2006-10-24 |
Millenium Pharmaceuticals, Inc. |
Genes, compositions, kits and methods for identification, assessment, prevention, and therapy of cervical cancer
|
|
EP1402070B1
(en)
*
|
2001-06-27 |
2012-01-11 |
Cancer Research Technology Limited |
Methods for the diagnosis of cancer based on the obcam and ntm genes
|
|
WO2003004681A2
(en)
*
|
2001-07-03 |
2003-01-16 |
Dendreon San Diego Llc |
Nucleic acid molecules encoding a transmembrane serine protease 20, the encoded polypeptides and methods based thereon
|
|
WO2003008589A1
(en)
*
|
2001-07-18 |
2003-01-30 |
Asahi Kasei Kabushiki Kaisha |
Elk1 PHOSPHORYLATION-ASSOCIATED GENE
|
|
JP2005508171A
(ja)
*
|
2001-11-02 |
2005-03-31 |
タノックス インコーポレーテッド |
Ｂ細胞悪性病変の診断及び予防に用いるためのｂ細胞リンパ腫特異抗原
|
|
US7582287B2
(en)
|
2001-12-17 |
2009-09-01 |
Zymogenetics, Inc. |
Method for treating cervical cancer
|
|
AU2003226131A1
(en)
|
2002-03-28 |
2003-10-13 |
Bristol-Myers Squibb Company |
Novel human cell surface protein with immunoglobulin folds, bgs-19
|
|
JP2005527614A
(ja)
|
2002-05-29 |
2005-09-15 |
デヴェロゲン アクチエンゲゼルシャフト フュア エントヴィックルングスビオローギッシェ フォルシュング |
膵臓特異性タンパク質
|
|
JP4488512B2
(ja)
|
2002-06-19 |
2010-06-23 |
レイベン バイオテクノロジーズ，インコーポレイティド |
新規のｒａａｇ１０細胞表面標的および当該標的を認識する抗体ファミリー
|
|
EP1565491B1
(en)
|
2002-11-20 |
2010-03-31 |
Cancer Research Technology Limited |
Antibodies binding to human magic roundabout (mr), polypeptides and uses thereof for inhibition of angiogenesis
|
|
US20040203132A1
(en)
|
2003-02-28 |
2004-10-14 |
Cognetix, Inc. |
Conus protein disulfide isomerase
|
|
BRPI0408705A
(pt)
|
2003-03-24 |
2006-03-07 |
Zymogenetics Inc |
método para produzir um anticorpo para um polipeptìdeo, anticorpo produzido pelo mesmo, anticorpo ou fragmento de anticorpo que se liga a um polipeptìdeo, métodos para reduzir ou inibir a proliferação ou diferenciação induzida pela il-20 de células hematopoiéticas e progenitores de célula hematopoiética, para reduzir a inflamação induzida pela il-20, para suprimir uma resposta inflamatória em um mamìfero com inflamação, para tratar um mamìfero afligido com uma doença inflamatória, para tratar um condição patológica em um paciente associada com a atividade de il-20
|
|
NZ544911A
(en)
|
2003-07-22 |
2008-12-24 |
Schering Ag |
RG1 antibodies and uses thereof
|
|
WO2005052001A2
(en)
|
2003-11-21 |
2005-06-09 |
Zymogenetics, Inc. |
Anti-il-20 receptor antibodies and binding partners and methods of using in inflammation
|
|
WO2005095448A2
(en)
*
|
2004-03-23 |
2005-10-13 |
Oscient Pharmaceuticals Corporation |
Method of synthesizing and purifying dkk proteins and dkk proteins obtained thereby
|
|
EP1734998A2
(en)
|
2004-04-14 |
2006-12-27 |
Genentech, Inc. |
Compositions and methods comprising an egfl7 antagonist for modulating vascular development
|
|
JP2007536931A
(ja)
*
|
2004-05-12 |
2007-12-20 |
ジェネンテック・インコーポレーテッド |
新規の遺伝子破壊、組成物およびそれらに関連する方法
|
|
US7732131B2
(en)
|
2004-08-03 |
2010-06-08 |
Innate Pharma S.A. |
Therapeutic and diagnostic methods and compositions targeting 4Ig-B7-H3 and its counterpart NK cell receptor
|
|
AU2005267722B2
(en)
|
2004-08-04 |
2009-10-08 |
Amgen Inc. |
Antibodies to Dkk-1
|
|
BRPI0516975A
(pt)
|
2004-10-22 |
2008-09-30 |
Zymogenetics Inc |
anticorpo ou seu fragmento de ligação a antìgeno, composição farmacêutica, imunoconjugado, hibridoma, anticorpo monoclonal, e, uso de um anticorpo ou seu fragmento de ligação a antìgeno
|
|
DE502004006789D1
(de)
|
2004-11-25 |
2008-05-21 |
Roche Diagnostics Gmbh |
Vorrichtung zum Analysieren von Proben
|
|
CN101243191B
(zh)
|
2004-11-29 |
2014-04-16 |
塞昆纳姆股份有限公司 |
用于检测甲基化dna的手段和方法
|
|
AU2005308916B2
(en)
|
2004-11-29 |
2011-07-21 |
Sequenom, Inc. |
Kits and methods for detecting methylated DNA
|
|
US7893032B2
(en)
|
2005-07-07 |
2011-02-22 |
Yale University |
NgR variants and compositions thereof for suppressing axonal growth inhibition
|
|
WO2007019859A2
(en)
|
2005-08-16 |
2007-02-22 |
Novozymes A/S |
Polypeptides of strain bacillus sp. p203
|
|
WO2007056227A2
(en)
|
2005-11-04 |
2007-05-18 |
Genentech, Inc. |
Use of complement pathway inhibitors to treat ocular diseases
|
|
CA2630432A1
(en)
*
|
2005-11-21 |
2007-07-19 |
Genentech, Inc. |
Novel gene disruptions, compositions and methods relating thereto
|
|
US7776573B2
(en)
|
2006-06-01 |
2010-08-17 |
Genentech, Inc. |
Crystal structure of CRIg and C3b:CRIg complex
|
|
WO2008003748A2
(en)
*
|
2006-07-07 |
2008-01-10 |
Novo Nordisk A/S |
Cd300lg polypeptides and their use in treating autoimmune diseases
|
|
EP2097455B1
(en)
|
2006-11-02 |
2014-10-22 |
Genentech, Inc. |
Humanized anti-factor d antibodies
|
|
AR065271A1
(es)
|
2007-02-09 |
2009-05-27 |
Genentech Inc |
Anticuerpos anti-robo4 y sus usos
|
|
JP2010133705A
(ja)
*
|
2007-03-16 |
2010-06-17 |
Perseus Proteomics Inc |
癌の診断薬及び治療薬
|
|
AR066660A1
(es)
|
2007-05-23 |
2009-09-02 |
Genentech Inc |
Prevencion y tratamiento de condiciones del ojo asociadas con su complemento
|
|
CN102046655B
(zh)
|
2008-04-02 |
2016-09-14 |
宏观基因有限公司 |
Bcr-复合体-特异性抗体和其使用方法
|
|
CR20170001A
(es)
|
2008-04-28 |
2017-08-10 |
Genentech Inc |
Anticuerpos anti factor d humanizados
|
|
US20090317400A1
(en)
|
2008-05-05 |
2009-12-24 |
Krzysztof Masternak |
Anti-IL 17A/IL-17F Cross-Reactive Antibodies and Methods of Use Thereof
|
|
RU2553517C2
(ru)
|
2008-05-06 |
2015-06-20 |
Дженентек, Инк. |
Варианты crig с созревшей аффинностью
|
|
AR075989A1
(es)
|
2009-04-10 |
2011-05-11 |
Lilly Co Eli |
Anticuerpo dkk -1 (dickkopf-1) humano disenado por ingenieria
|
|
MX2011011729A
(es)
|
2009-05-05 |
2012-04-10 |
Novimmune Sa |
Anticuerpo anti il-17f y metodos de uso de los mismos.
|
|
TWI428142B
(zh)
|
2009-05-08 |
2014-03-01 |
Genentech Inc |
人類化之抗－ｅｇｆｌ７抗體及其使用方法
|
|
WO2010131185A1
(en)
|
2009-05-12 |
2010-11-18 |
Pfizer Inc. |
Blocking anti-dkk-1 antibodies and their uses
|
|
WO2011020024A2
(en)
|
2009-08-13 |
2011-02-17 |
The Johns Hopkins University |
Methods of modulating immune function
|
|
CN107693791B
(zh)
|
2010-02-26 |
2022-06-07 |
诺沃—诺迪斯克有限公司 |
包含稳定抗体的组合物
|
|
GEP201706660B
(en)
|
2010-03-04 |
2017-04-25 |
Macrogenics Inc |
Antibodies reactive with b7-h3, immunologically active fragments thereof and uses thereof
|
|
US8802091B2
(en)
|
2010-03-04 |
2014-08-12 |
Macrogenics, Inc. |
Antibodies reactive with B7-H3 and uses thereof
|
|
AU2011257219B2
(en)
|
2010-05-28 |
2014-12-04 |
Novo Nordisk A/S |
Stable multi-dose compositions comprising an antibody and a preservative
|
|
US9487587B2
(en)
|
2013-03-05 |
2016-11-08 |
Macrogenics, Inc. |
Bispecific molecules that are immunoreactive with immune effector cells of a companion animal that express an activating receptor and cells that express B7-H3 and uses thereof
|
|
US20160024181A1
(en)
|
2013-03-13 |
2016-01-28 |
Moderna Therapeutics, Inc. |
Long-lived polynucleotide molecules
|
|
KR20160042438A
(ko)
|
2013-08-12 |
2016-04-19 |
제넨테크, 인크. |
보체-연관 상태의 치료를 위한 조성물 및 방법
|
|
US10179821B2
(en)
|
2014-05-01 |
2019-01-15 |
Genentech, Inc. |
Anti-factor D antibodies
|
|
WO2017075173A2
(en)
|
2015-10-30 |
2017-05-04 |
Genentech, Inc. |
Anti-factor d antibodies and conjugates
|
|
US10654932B2
(en)
|
2015-10-30 |
2020-05-19 |
Genentech, Inc. |
Anti-factor D antibody variant conjugates and uses thereof
|
|
MX2018012433A
(es)
|
2016-04-15 |
2019-03-01 |
Macrogenics Inc |
Moleculas de union b7-h3 novedosas, conjugados anticuerpo-farmaco de los mismos y metodos de uso de los mismos.
|
|
KR102619197B1
(ko)
|
2017-01-23 |
2024-01-03 |
리제너론 파마슈티칼스 인코포레이티드 |
Hsd17b13 변종 및 이것의 용도
|
|
KR20240125690A
(ko)
|
2017-10-11 |
2024-08-19 |
리제너론 파마슈티칼스 인코포레이티드 |
Pnpla3 i148m 변이를 발현하는 환자의 간 질환의 치료에서의 hsd17b13의 저해
|
|
CN109708935A
(zh)
*
|
2018-12-15 |
2019-05-03 |
济南艾迪康医学检验中心有限公司 |
一种高分辨外周血染色体g带的制作方法
|